 Exclusive contents: images and/or videos
Direct stenting is becoming the most frequently used technique in the treatment of coronary stenosis, since it is more cost-effective and less time-consuming. Furthermore, the higher periprocedural success rate and availability is leading to a higher case load. This may bare a higher frequency of less common complications, such as unwanted stent strut deformation. We recently encountered this complication during two cases of direct stenting, using two different cobalt chromium stents with very thin struts.
click here to reroll the summary
We report a case of coronary stent fracture occurring after treatment of an ostial lesion in an anomalous right coronary artery arising from the left coronary sinus. Stent fracture occurred at the point of exit from the aortic wall. Analysis suggests that this junction between immobile and free segments of artery acted as a hinge point for repetitive stent flexion during the cardiac cycle, leading to metal fatigue and strut fracture. Examples like this demonstrate that unexpected complications can occur when using stents in unusual circumstances and that caution and surveillance may be necessary.
click here to reroll the summary
Sudden cardiac arrest (SCA) a leading cause of death in the western world and coronary heart disease may be responsible for 60-80 % of these deaths. Consequently, an increasing number of these patients will be admitted directly for coronary intervention during automatic mechanical chest compression. Manually performed cardiopulmonary resuscitation (CPR) is not possible during percutaneous coronary intervention (PCI). However, mechanical chest compression devices may be an alternative. We report on two cases in which ongoing chest compression was associated with reversed diastolic blood flow in the left anterior descending coronary artery (LAD). This may be a sign of the development of ischaemic contracture despite adequate systemic blood pressure during mechanical chest compression.
click here to reroll the summary
Acute coronary occlusions leading to myocardial infarctions tend to cluster in predictable “hot spots” within the proximal third of the coronary arteries. We describe the case of a 47 year old man with a complex cardiovascular risk profile presenting with unstable angina, in whom both coronary angiography and grey-scale intravascular ultrasound revealed a non-significant obstruction in the distal left main coronary artery. Virtual histology intravascular ultrasound analysis defined a vulnerable plaque, which made us apply a local plaque sealing strategy using a sirolimus-eluting stent.
click here to reroll the summary
Percutaneous coronary intervention (PCI) is becoming increasing accepted as a viable treatment option for patients with left main coronary artery (LMCA) disease deemed unsuitable for coronary artery bypass grafting (CABG). Nonetheless, the risk of ischaemic complications during or after the procedure is considerable in such patients. Supportive techniques may limit ischaemia during PCI and maintain haemodynamic stability. The TandemHeart® is a percutaneous left ventricular assist device with a centrifugal continuous flow pump providing a systemic output of up to 4L/min through a retrograde femoral access, which can be deployeded percutaneously in the catheterisation laboratory at the time of the coronary procedure. Oxygenised blood is harvested trans-septally from the left atrium. The TandemHeart® may lead to sustained aortic valve closure because of a continuous supraventricular pressure maintained in the aorta. We report a case of successful PCI of the LMCA after implantation of a TandemHeart® device for circulatory support, This case is unusual in that the presence of the TandemHeart® led to temporary aortic valve closure and pulseless coronary flow throughout the interventional procedure.
click here to reroll the summary
Editorial
2
TVS meets EuroPCR
EuroInterv.2007;3:17-19
EAPCI column
Focus article
6
European perspective in the recanalisation of Chronic Total Occlusions (CTO): consensus document from the EuroCTO Club
Di Mario C., Werner G., Sianos G., Galassi A., Büttner J., Dudek D., Chevalier B., Lefèvre T., Schofer J., Koolen J., Sievert H., Reimers B., Fajadet J., Colombo A., Gershlick A., Serruys P.W., Reifart N., the EuroCTO Club for
EuroInterv.2007;3:30-43
7
Percutaneous coronary intervention of bifurcation lesions: state-of-the-art. Insights from the second meeting of the European Bifurcation Club
Legrand V., Thomas M., Zelízko M., de Bruyne B., Reifart N., Steigen T., Hildick-Smith D., Albiero R., Darremont O., Stankovic G., Pan M., Lassen J., Louvard Y., Lefèvre T.
EuroInterv.2007;3:44-49
Clinical research
10
Risk factors for major complications due to delay in surgery in staged carotid stenting and coronary bypass graft surgery
Kassaian S., Alidoosti M., Saleh D., Zeinali A., Salarifar M., Sahraian A., Shirani S., Kazazi E., Darvish S., Marzban M., Abbasi S., Massumi A.
EuroInterv.2007;3:60-66
11
Circulating endothelial progenitor cells predict angiographic and intravascular ultrasound outcome following percutaneous coronary interventions in the HEALING-II trial: evaluation of an endothelial progenitor cell capturing stent
Duckers H., Silber S., de Winter R., den Heijer P., Rensing B., Rau M., Mudra H., Benit E., Verheye S., Wijns W., Serruys P.W.
EuroInterv.2007;3:67-75
12
Safety of direct stenting with the Endeavor stent: results of the Endeavor II continued access registry
Schultheiss H.-P., Grube E., Kuck K.-H., Suttorp M., Heuer H., Bonnier H., Popma J., Kuntz R., Fajadet J., Wijns W., for the Endeavor II Continued Access Investigators
EuroInterv.2007;3:76-81
13
The European cobalt STent with Antiproliferative for Restenosis trial (EuroSTAR): 12 month results
Dawkins K., Verheye S., Schühlen H., Dens J., Mudra H., Rutsch W., Stella P., Di Mario C., Thomas M., Serruys P.W., Colombo A.
EuroInterv.2007;3:82-88
16
In vivo validation of a novel three-dimensional quantitative coronary angiography system (CardiOp-B™): comparison with a conventional two-dimensional system (CAAS II™) and with special reference to optical coherence tomography
Tsuchida K., van der Giessen W.J., Patterson M., Tanimoto S., García-García H., Regar E., Ligthart J., Maugenest A.-M., Maatrijk G., Wentzel J., Serruys P.W.
EuroInterv.2007;3:100-108
Expert review
Experimental research
23
First experience with remote left ventricular mapping and transendocardial cell injection with a novel integrated magnetic navigation-guided electromechanical mapping system
Perin E., Silva G., Fernandes M., Munger T., Pandey A., Sehra R., Talcott M., Bichard C., Creed J., Wong J., Oliveira E., Zheng Y., Canales J., Cardoso C., Patterson M., Serruys P.W.
EuroInterv.2007;3:142-148
Image in cardiology
Issue 9 has been released thanks to the support of the following partners:
- Cordis, a Johnson & Johnson company
- Boston Scientific
- Medtronic
- Abbott Vascular Devices
- Terumo
- Hexacath
- GE Healthcare
- Edwards Lifesciences
- Jenavalve Technology GmbH
|